2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Top Cited Papers
- 3 May 2022
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 145 (18), E895-E1032
- https://doi.org/10.1161/cir.0000000000001063
Abstract
Aim: The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure” replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the “2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure.” The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure. Methods: A comprehensive literature search was conducted from May 2020 to December 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from MEDLINE (PubMed), EMBASE, the Cochrane Collaboration, the Agency for Healthcare Research and Quality, and other relevant databases. Additional relevant clinical trials and research studies, published through September 2021, were also considered. This guideline was harmonized with other American Heart Association/American College of Cardiology guidelines published through December 2021. Structure: Heart failure remains a leading cause of morbidity and mortality globally. The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with heart failure, with the intent to improve quality of care and align with patients’ interests. Many recommendations from the earlier heart failure guidelines have been updated with new evidence, and new recommendations have been created when supported by published data. Value statements are provided for certain treatments with high-quality published economic analyses.This publication has 1309 references indexed in Scilit:
- Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathyBasic Research in Cardiology, 2013
- Diagnoses and Timing of 30-Day Readmissions After Hospitalization for Heart Failure, Acute Myocardial Infarction, or PneumoniaJAMA, 2013
- Progression of Left Ventricular Diastolic Dysfunction and Risk of Heart FailureJAMA, 2011
- Health Risks, Chronic Diseases, and Access to Care Among US Pacific IslandersJournal of General Internal Medicine, 2010
- Consistency With the DASH Diet and Incidence of Heart FailureJAMA Internal Medicine, 2009
- Epidemiology of Incident Heart Failure in a Contemporary Elderly CohortJAMA Internal Medicine, 2009
- Efficacy and Safety of Exercise Training in Patients With Chronic Heart FailureJAMA, 2009
- Differences in the Incidence of Congestive Heart Failure by EthnicityJAMA Internal Medicine, 2008
- Discordance Between Patient-Predicted and Model-Predicted Life Expectancy Among Ambulatory Patients With Heart FailureJAMA, 2008
- Trends in Heart Failure Incidence and Survival in a Community-Based PopulationJAMA, 2004